Centene (CNC)
(Delayed Data from NYSE)
$72.44 USD
+0.82 (1.14%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $72.43 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$72.44 USD
+0.82 (1.14%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $72.43 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum A VGM
Zacks News
Luminex (LMNX) Banks on Solid Product Line, Competition Rife
by Zacks Equity Research
Luminex's (LMNX) extensive product line and rising revenues raise optimism. However, a challenging reimbursement scenario is likely to mar prospects.
Abiomed's Extended FDA Nod for Impella Refines PCI Diagnosis
by Zacks Equity Research
Abiomed (ABMD) gets second FDA PMA for its flagship Impella in a row, with a view to treating patients with High Risk PCI.
Hologic Banks on Diagnostics, GYN Surgical Prospects Bright
by Zacks Equity Research
Hologic (HOLX) stays upbeat about GYN Surgical on the recent commercial launch of MyoSure MANUAL device in the United States.
Pharmacy Services Aid CVS Health, Aetna Deal an Upside Too
by Zacks Equity Research
CVS Health (CVS) is likely to earn $750 million from near-term synergies after the completion of Aetna acquisition deal.
Inogen (INGN) Gains on Diverse Product Line, Competition Rife
by Zacks Equity Research
Inogen (INGN) rides on POC growth. Existing market challenges likely to mar prospects.
Exactech (EXAC) Gets Acquired by TPG Capital, Goes Private
by Zacks Equity Research
TPG Capital acquires Exactech (EXAC) with a view to cash in on its resources and gain a foothold in the orthopedics market.
DaVita (DVA) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
DaVita's (DVA) fourth-quarter results to hurt from lackluster revenues stemming from high debts and labor union hurdles.
Can Geographical Sales Aid DENTSPLY's (XRAY) Q4 Earnings?
by Zacks Equity Research
DENTSPLY (XRAY) anticipates lower regional sales to dent results in Q4. The company continues to focus on operational excellence.
Centene (CNC) Tops Q4 Earnings and Revenues
by Zacks Equity Research
Centene's (CNC) fourth - quarter operating earnings and revenues handily surpassed our Zacks Consensus Estimate.
Medical Stocks Reporting Q4 Earnings on Feb 6: CNC, WCG, HQY
by Zacks Equity Research
Medical stocks' fourth-quarter results are likely to benefit from higher membership, increase in premium, partly offset by high costs.
Can Solid Medicaid Business Boost Centene (CNC) Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are expected to be supported by membership growth and cost-saving initiatives.
Why Centene Corporation (CNC) Might Surprise This Earnings Season
by Zacks Equity Research
Centene (CNC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
4 Reasons Why You Should Buy Accuray (ARAY) Stock Right Now
by Zacks Equity Research
Accuray (ARAY) rides high on its Radixact platform and latest software overhaul.
Will Higher Membership, Revenues Aid Cigna (CI) Q4 Earnings?
by Zacks Equity Research
Cigna's (CI) Q4 earnings should likely be aided by higher revenues from its healthcare, global supplement units, partly offset by Medicare membership loss.
AET vs. HCA: Which Stock is Poised for Better Q4 Earnings?
by Zacks Equity Research
Let us try to find out which stock between Aetna (AET) and HCA Healthcare (HCA) is better positioned for an earnings beat in the fourth quarter
AngioDynamics Receives FDA Nod, to Treat Pancreatic Cancer
by Zacks Equity Research
AngioDynamics (ANGO) gets flagship NanoKnife designated with EAP.
Will HCA Healthcare's (HCA) Earnings Beat Estimates in Q4?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter results are expected to be driven by higher admissions
Varian Medical (VAR) Beats Q1 Earnings & Revenue Estimates
by Zacks Equity Research
HyperArc and Halcyon platforms drive Varian Medical's (VAR) Q1 results.
Health Insurers Bask Under Rising Insured, Medicare Business
by Zacks Equity Research
Health insurers have capitalized on a surge in insured rates by raking in members, who added to their top-line growth.
PerkinElmer Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
PerkinElmer's (PKI) shares hit a new 52-week high on the back of broad product spectrum and acquisition-led growth.
4 Great Healthcare Stocks to Buy Ahead of Q4 Earnings
by Swarup Gupta
An ageing population and steady demand for healthcare services continue to make stocks from the sector a lucrative option.
CVS Health Grows on Pharmacy Services, Retail Remains a Drag
by Zacks Equity Research
CVS Health's (CVS) strong Pharmacy Services business continues to gain from a sturdy Specialty Pharmacy. However, its highly competitive retail pharmacy business raises concern.
Can Tenet Healthcare (THC) Get Back on Growth Path in 2018?
by Zacks Equity Research
Shares of Tenet Healthcare (THC) have lost significantly last year owing to lower revenues, weak margins, high bad debts and expenses.
Will Intuitive Surgical (ISRG) Disappoint in Q4 Earnings?
by Zacks Equity Research
Intuitive Surgical (ISRG) is expected to witness growth across da Vinci Surgical and Service segments. Instruments and accessories revenues are also expected to increase year over year.
DaVita (DVA) Partners with Epic to Launch EHR for Patients
by Zacks Equity Research
DaVita (DVA) collaborates with Epic to introduce electronic health record facility for patients, reduce costs and enhance healthcare.